KRAS mutation and primary tumor location do not affect efficacy of bevacizumab-containing chemotherapy in stagae IV colorectal cancer patients

Scientific Reports
De-Cong SunGuanghai Dai

Abstract

This study aims to investigate the efficacy of bevacizumab-combined chemotherapy (BCC) in Chinese stage IV colorectal cancer (CRC), and analyze the relationship between clinicopathological features with survival. Patients with stage IV CRC treated with BCC were analyzed retrospectively. 217 metastatic CRC (mCRC) patients were collected, out of which79 were right-sided CRCs and 138 were left-sided ones. Patients with Eastern Cooperative Oncology Group (ECOG) performance status ≤2, single agent chemotherapy, poor/mucous/signet ring cell component, second-and further-line of bevacizumab administration, multiple metastasis sites had comparatively worse survival. Among 141 patients with known KRAS status, 55 patients harbored KRAS mutation and 86 had wild type KRAS. The ORR and DCR were 41.9% and 78.9%, respectively, in patients with wild type KRAS, while ORR and DCR was 38.7% and 77.9%, respectively, in patients with KRAS mutation. The median PFS of patients with wild type and mutant KRAS were 8.38, and9.59 months, respectively; whereas the OS was 23.00 and 21.26 months, respectively for mCRC patients with wild-type and mutant KRAS. Cumulatively, our study indicated that BCC was effective and beneficial for Chinese stage IV CRC pat...Continue Reading

References

Oct 29, 2000·The American Journal of Gastroenterology·W A BleekerJ T Plukker
Sep 7, 2002·International Journal of Cancer. Journal International Du Cancer·Barry Iacopetta
Mar 29, 2003·Swiss Surgery = Schweizer Chirurgie = Chirurgie Suisse = Chirurgia Svizzera·P GervazP Morel
Jun 4, 2004·The New England Journal of Medicine·Herbert HurwitzFairooz Kabbinavar
Feb 9, 2007·Journal of Clinical Pharmacy and Therapeutics·I Krämer, H-P Lipp
Apr 20, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Bruce J GiantonioUNKNOWN Eastern Cooperative Oncology Group Study E3200
Apr 19, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Leonard B SaltzJim Cassidy
Jul 16, 2008·Annals of Surgical Oncology·Robert A MeguidNita Ahuja
May 2, 2009·Annals of Oncology : Official Journal of the European Society for Medical Oncology·E Van CutsemUNKNOWN First BEAT investigators
Dec 17, 2009·Diseases of the Colon and Rectum·Frank BenedixUNKNOWN Colon/Rectum Carcinomas (Primary Tumor) Study Group
Mar 8, 2011·Cell·Douglas Hanahan, Robert A Weinberg
Nov 22, 2012·The Lancet Oncology·Jaafar BennounaUNKNOWN ML18147 Study Investigators
Aug 22, 2013·World Journal of Gastroenterology : WJG·Efstathios T Pavlidis, Theodoros E Pavlidis
Sep 11, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Frank A SinicropeSteven R Alberts
Jul 25, 2014·Annals of Oncology : Official Journal of the European Society for Medical Oncology·E MissiagliaS Tejpar
Jan 7, 2015·CA: a Cancer Journal for Clinicians·Rebecca L SiegelAhmedin Jemal
Feb 26, 2015·Journal of the National Cancer Institute·Fotios LoupakisHeinz-Josef Lenz
Mar 13, 2016·Clinical Colorectal Cancer·Hui-Li WongPeter Gibbs

❮ Previous
Next ❯

Software Mentioned

SPSS

Related Concepts

Related Feeds

Carcinoma, Basal Cell

Basal cell carcinoma is a form of malignant skin cancer found on the head and neck regions and has low rates of metastasis. Discover the latest research on basal cell carcinoma here.